This financing round attracted many new investors including Amgen; NVentures, NVIDIA's venture capital arm; MAPS Capital (Mirae Asset Group); and Pictet Alternative Advisors. Additionally, company founder, Flagship Pioneering, and every Series B investor, including a wholly-owned subsidiary of the Abu Dhabi Investment Authority (ADIA); Fidelity Management & Research Company; funds and accounts advised by T.

这轮融资吸引了包括安进在内的许多新投资者；NVentures，NVIDIA的风险投资部门；MAPS资本（Mirae资产集团）；和Pictet替代顾问。此外，公司创始人，旗舰开拓者和每个B系列投资者，包括阿布扎比投资局（ADIA）的合资子公司；保真度管理研究公司；T.建议的资金和账户。

Rowe Price Associates, Inc.; ARCH Venture Partners; and March Capital, participated in the round.Generate:Biomedicines is the first drug generation company pioneering a machine learning-powered generative biology platform with the ability to create new drugs on demand across a wide range of biologic modalities.

Rowe Price Associates，Inc。；ARCH Venture Partners；和三月首都，参加了这一轮。生成：Biomedicines是第一家开创机器学习动力生成生物学平台的药物生成公司，能够在各种生物模式下按需创建新药。

The Generate Platform - which is a continuous loop to generate, build, measure, and learn - can drastically increase the speed at which targets and therapeutics are identified and validated. This will improve the specificity of target engagement by generated proteins and reduce the time and cost of identifying and developing clinical candidates..

生成平台-这是一个生成，构建，测量和学习的连续循环-可以大大提高识别和验证目标和治疗方法的速度。这将提高产生的蛋白质对靶标参与的特异性，并减少鉴定和开发临床候选物的时间和成本。。